ArticlePatient preference and adherence2021

Usability of the Certolizumab Pegol Auto-Injection Device in Australian Patients with Chronic Rheumatic Diseases: Results from a Market Research Study.

Juan Aw et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.